Lidoderm and Oxybutynin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lidoderm (lidocaine) and Oxybutynin (oxybutynin). Common drug interactions include productive cough among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Lidoderm and Oxybutynin. It is created by eHealthMe based on reports of 93 people who take the same drugs from the FDA, and is updated regularly.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.



On Jul, 16, 2026

93 people who take Lidoderm and Oxybutynin together, and have interactions are studied.

Lidoderm and Oxybutynin drug interactions.

What are the common drug interactions of Lidoderm and Oxybutynin, by gender? *:

female:

  1. Productive cough
  2. Skin ulcer
  3. Small intestinal obstruction (blockage in small intestine)
  4. Spinal stenosis (narrowing of spinal column)
  5. Surgery
  6. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  7. Urinary tract infection
  8. Nausea (feeling of having an urge to vomit)
  9. Fatigue (feeling of tiredness)
  10. Anxiety

male:

  1. Asthenia (weakness)
  2. Death
  3. Influenza
  4. Liver injury
  5. Melaena (the passage of black, tarry stools)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Suicide attempt
  8. Urinary retention (the inability to completely or partially empty the bladder)
  9. Urinary tract infection
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Lidoderm and Oxybutynin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal hernia
  2. Influenza like illness
  3. Injection site erythema (redness at injection site)
  4. Injection site swelling
  5. Nausea (feeling of having an urge to vomit)
  6. Small intestinal obstruction (blockage in small intestine)

20-29:

n/a

30-39:

  1. Altered state of consciousness (altered state of mind)
  2. Fatigue (feeling of tiredness)
  3. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  4. Post-traumatic stress disorder
  5. Weight decreased

40-49:

  1. Gastric bypass
  2. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  6. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  7. Urinary tract infection
  8. Blood glucose increased
  9. Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

50-59:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Cold sweat
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Cough
  7. Depressed level of consciousness
  8. Dysphonia (speech disorder attributable to a disorder of phonation)
  9. Dyspnoea (difficult or laboured respiration)
  10. Emotional distress

60+:

  1. Urinary tract infection
  2. Diarrhoea
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Sinusitis (inflammation of sinus)
  7. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  8. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  9. Urinary tract infection enterococcal
  10. Viral infection

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 23 people, 24.73%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 20 people, 21.51%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 19.35%
  4. High Blood Cholesterol: 15 people, 16.13%
  5. Hypersensitivity: 13 people, 13.98%
  6. Constipation: 13 people, 13.98%
  7. High Blood Pressure: 13 people, 13.98%
  8. Stress And Anxiety: 12 people, 12.90%
  9. Depression: 11 people, 11.83%
  10. Nausea (feeling of having an urge to vomit): 9 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Lidoderm and Oxybutynin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lidoderm and Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidoderm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxybutynin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine and oxybutynin (the active ingredients of Lidoderm and Oxybutynin, respectively), and Lidoderm and Oxybutynin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: